MANSFIELD, Mass., Sept. 1, 2011 /PRNewswire/ -- PrimeraDx, a leading provider of multiplex qPCR solutions, today announced that Matt McManus MD, PhD, President and CEO, will present at the Stifel Nicolaus 2011 Healthcare Conference at 8:35 a.m. ET on Thursday, September 8th, 2011, at the Four Seasons Hotel, Boston, Massachusetts.
PrimeraDx is dedicated to the high growth field of molecular diagnostics. The Company has developed a unique platform for high-multiplex, quantitative, real-time PCR based on its proprietary STAR technology, implemented on the walk-away ICEPlex instrument system. PrimeraDx is developing a broad range of applications in oncology, infectious disease, companion diagnostics and multiple non-clinical molecular markets, both through its own efforts and in collaboration with partners. The Company is backed by a strong group of experienced venture-capital investors, including Abingworth, InterWest Partners, CHL Medical Partners, and Malaysia Technology Development Corporation. The Company's website is: www.primeradx.com or www.multiplexpcr.com.
CONTACT: Andrew Bond, 508-618-2300, email@example.com